Rocket


News + Filings
Transactions
Holdings



FMR LLC

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
07/25/2023Turnstone Biologics Corp. ConversionCommon Stock91.7k$0.00$0F-Prime Capital Partners Healthcare Fund V LP07/25/2023
07/25/2023Turnstone Biologics Corp. ConversionCommon Stock106.5k$0.00$0F-Prime Capital Partners Healthcare Fund V LP07/25/2023
07/25/2023Turnstone Biologics Corp. ConversionCommon Stock150.8k$0.00$0F-Prime Capital Partners Healthcare Fund V LP07/25/2023
07/25/2023Turnstone Biologics Corp. ConversionCommon Stock483.7k$0.00$0F-Prime Capital Partners Healthcare Fund V LP07/25/2023
07/25/2023Turnstone Biologics Corp. ConversionCommon Stock296.4k$0.00$0Impresa Fund III Limited Partnership07/25/2023
07/25/2023Turnstone Biologics Corp. ConversionSeries D Preferred Stock91.7k$0.00$0F-Prime Capital Partners Healthcare Fund V LP07/25/2023
07/25/2023Turnstone Biologics Corp. ConversionSeries C Preferred Stock106.5k$0.00$0F-Prime Capital Partners Healthcare Fund V LP07/25/2023
07/25/2023Turnstone Biologics Corp. ConversionSeries B-2 Preferred Stock150.8k$0.00$0F-Prime Capital Partners Healthcare Fund V LP07/25/2023
07/25/2023Turnstone Biologics Corp. ConversionSeries B-1 Preferred Stock483.7k$0.00$0F-Prime Capital Partners Healthcare Fund V LP07/25/2023
07/25/2023Turnstone Biologics Corp. ConversionSeries B-2 Preferred Stock296.4k$0.00$0Impresa Fund III Limited Partnership07/25/2023
07/25/2023Turnstone Biologics Corp. ConversionCommon Stock4.9k$0.00$0F-Prime Capital Partners Healthcare Advisors Fund V LP07/25/2023
07/25/2023Turnstone Biologics Corp. ConversionSeries B-2 Preferred Stock4.9k$0.00$0F-Prime Capital Partners Healthcare Advisors Fund V LP07/25/2023
06/27/2023Fidelity Private Credit Fund PurchaseClass I Common Shares of Beneficial Interest346.7k$25.23$8.7MFidelity Multi-Strategy Credit Fund06/27/2023
02/07/2023Structure Therapeutics Inc. ConversionOrdinary Shares965.1k$0.00$0F-Prime Capital Partners Life Sciences Fund VI LP02/07/2023
02/07/2023Structure Therapeutics Inc. ConversionOrdinary Shares57.5k$0.00$0F-Prime Capital Partners Life Sciences Advisors Fund VI LP02/07/2023
02/07/2023Structure Therapeutics Inc. ConversionOrdinary Shares10.2k$0.00$0F-Prime Capital Partners Life Sciences Advisors Fund VI LP02/07/2023
02/07/2023Structure Therapeutics Inc. ConversionOrdinary Shares7.4k$0.00$0F-Prime Capital Partners Life Sciences Advisors Fund VI LP02/07/2023
02/07/2023Structure Therapeutics Inc. ConversionOrdinary Shares6.9k$0.00$0F-Prime Capital Partners Life Sciences Advisors Fund VI LP02/07/2023
02/07/2023Structure Therapeutics Inc. ConversionOrdinary Shares3.6M$0.00$0Entities managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned02/07/2023
02/07/2023Structure Therapeutics Inc. ConversionOrdinary Shares568.1k$0.00$0Entities managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned02/07/2023
02/07/2023Structure Therapeutics Inc. ConversionOrdinary Shares414.6k$0.00$0Entities managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned02/07/2023
02/07/2023Structure Therapeutics Inc. ConversionOrdinary Shares214.7k$0.00$0Entities managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned02/07/2023
02/07/2023Structure Therapeutics Inc. ConversionSeries A Convertible Preferred Shares965.1k$0.00$0F-Prime Capital Partners Life Sciences Fund VI LP02/07/2023
02/07/2023Structure Therapeutics Inc. ConversionSeries A Convertible Preferred Shares57.5k$0.00$0F-Prime Capital Partners Life Sciences Advisors Fund VI LP02/07/2023
02/07/2023Structure Therapeutics Inc. ConversionSeries A+ Convertible Preferred Shares10.2k$0.00$0F-Prime Capital Partners Life Sciences Advisors Fund VI LP02/07/2023
02/07/2023Structure Therapeutics Inc. ConversionSeries B Convertible Preferred Shares7.4k$0.00$0F-Prime Capital Partners Life Sciences Advisors Fund VI LP02/07/2023
02/07/2023Structure Therapeutics Inc. ConversionSeries B-1 Convertible Preferred Shares6.9k$0.00$0F-Prime Capital Partners Life Sciences Advisors Fund VI LP02/07/2023
02/07/2023Structure Therapeutics Inc. ConversionSeries A Convertible Preferred Shares3.6M$0.00$0Entities managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned02/07/2023
02/07/2023Structure Therapeutics Inc. ConversionSeries A+ Convertible Preferred Shares568.1k$0.00$0Entities managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned02/07/2023
02/07/2023Structure Therapeutics Inc. ConversionSeries B Convertible Preferred Shares414.6k$0.00$0Entities managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned02/07/2023
02/07/2023Structure Therapeutics Inc. ConversionSeries B-1 Convertible Preferred Shares214.7k$0.00$0Entities managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned02/07/2023
09/06/2022Beam Therapeutics Inc.BEAMSaleCommon Stock551$54.25$29.9kF-Prime Inc.09/06/2022
09/06/2022Beam Therapeutics Inc.BEAMOther (acquisition)Common Stock551$0.00$0F-Prime Inc.09/06/2022
09/06/2022Beam Therapeutics Inc.BEAMOther (disposition)Common Stock25.6k$0.00$0F-Prime Capital Partners Healthcare Advisors Fund V LP09/06/2022
08/05/2022Beam Therapeutics Inc.BEAMSaleCommon Stock167$61.00$10.2kImpresa Fund III Limited Partnership08/04/2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy